Chesterfield Royal Hospital NHS Foundation Trust Deploys E-Prescribing Solution from JAC

JACChesterfield Royal Hospital NHS Foundation Trust has reported on the success of its deployment of JAC's Electronic Prescribing and Medicines Administration (EPMA) system. The Trust began rolling out the system in May 2010, and it is now live in the hospital's surgical, orthopaedic and medical wards, as well as in theatres.

The Trust provides services to over 375,000 people living in and around North Derbyshire. As well as providing 24-hour accident and emergency care, the Trust also provides specialist children's services and manages a small birth centre in the Derbyshire Dales.

The EPMA system assists the Trust in reducing prescribing and administrative errors, as well as providing an effective method to facilitate auditing across the organisation.

In addition to the EPMA system, the Trust has also invested in mobile workstations, which house laptops to enable the use of EPMA to prescribe and administer medicines at patients' bedsides. This enables staff to spend more time with patients, reducing prescribing errors and improving the patient experience.

Martin Shepherd, Head of Medicines Management at Chesterfield Royal Hospital NHS Foundation Trust said: "It is widely recognised that electronic prescribing systems improve the legibility of prescriptions and removes the possibility of prescriptions being lost or misplaced. The EPMA system is a reliable and effective method to help improve safety in prescribing and ensure trust-wide access to the medicines record, supporting the prescribing, administering and dispensing of medicines."

On assessment the Trust selected JAC's e-prescribing solution for its rich functionality and ability to meet its specific requirements for trust-wide deployment. The Trust aims to implement the EPMA system into its remaining wards by March 2012, including obstetrics, gynaecology, paediatrics and day surgery.

In addition to improving patient safety and reducing prescription errors, e-prescribing can also deliver significant cost savings through closer monitoring of prescriptions and medicines administration, and improve the communication between hospital departments and pharmacies, resulting in more consistent care across the Trust.

The e-prescribing system also incorporates First DataBank Multilex, the UK's leading clinical drug database, to support safe electronic prescribing with patient-specific decision support.

About JAC
JAC is the UK's leading supplier of medicines management solutions. JAC provides pharmacy stock control, e-prescribing and medicines administration as a single integrated solution along with ward-based automation technologies for the safe & secure storage of medicines and medical equipment.

With the largest installed base of Electronic Prescribing and Medicines Administration systems in UK hospitals, the JAC solution improves patient safety by reducing prescribing and administration mistakes that could result in medication errors and adverse drug events.

EPMA also facilitates wider improvements in clinical practice, including: reductions in paperwork and transcriptions; improved audit trails for medication; performance monitoring and intelligence; reporting greater consistency and continuity of care between primary and secondary care settings; and more effective communication between hospital departments and pharmacies. The system incorporates the UK's leading Clinical drug database (FirstDatabank Multilex), to support safe and effective electronic prescribing through its clinical checking, reducing the risk of medication errors and increasing patient safety.

Most Popular Now

Herefordshire and Worcestershire Health …

Herefordshire and Worcestershire Health and Care NHS Trust has successfully implemented Alcidion's Miya Precision platform to streamline bed management workflow across seven community hospitals in Worcestershire. The trust delivers community...

A Shortcut for Drug Discovery

For most human proteins, there are no small molecules known to bind them chemically (so called "ligands"). Ligands frequently represent important starting points for drug development but this knowledge gap...

New Horizon Europe Funding Boosts Europe…

The European Commission has announced the launch of new Horizon Europe calls, with a substantial funding pool of over €112 million. These calls are aimed primarily at pioneering projects in...

Cleveland Clinic Study Finds AI can Deve…

Cleveland Clinic researchers developed an artficial intelligence (AI) model that can determine the best combination and timeline to use when prescribing drugs to treat a bacterial infection, based solely on...

New AI-Technology Estimates Brain Age Us…

As people age, their brains do, too. But if a brain ages prematurely, there is potential for age-related diseases such as mild-cognitive impairment, dementia, or Parkinson's disease. If "brain age...

With Huge Patient Dataset, AI Accurately…

Scientists have designed a new artificial intelligence (AI) model that emulates randomized clinical trials at determining the treatment options most effective at preventing stroke in people with heart disease. The model...

Radboud University Medical Center and Ph…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Radboud University Medical Center have signed a hospital-wide, long-term strategic partnership that delivers the latest patient monitoring...

GPT-4, Google Gemini Fall Short in Breas…

Use of publicly available large language models (LLMs) resulted in changes in breast imaging reports classification that could have a negative effect on patient management, according to a new international...

ChatGPT fails at heart risk assessment

Despite ChatGPT's reported ability to pass medical exams, new research indicates it would be unwise to rely on it for some health assessments, such as whether a patient with chest...

Study Shows ChatGPT Failed when Challeng…

With artificial intelligence (AI) poised to become a fundamental part of clinical research and decision making, many still question the accuracy of ChatGPT, a sophisticated AI language model, to support...

Virtual Reality Shows Promise in Fightin…

A new study published in JMIR Mental Health sheds light on the promising role of virtual reality (VR) in treating major depressive disorder (MDD). Titled "Examining the Efficacy of Extended...

AXREM and Highland Marketing Partner to …

AXREM represents member companies that collectively provide UK hospitals with most of their diagnostic medical imaging technology, and radiotherapy equipment. The association has seen substantial growth in recent years, with membership...